BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Masitinib readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Masitinib\, from ClinicalTrials.gov estim
 ates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT03127267-787@assetmemo.bio
DTSTAMP:20261121T004052Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:Masitinib: Phase 3 readout est. (NCT03127267)
DESCRIPTION:Masitinib\, phase 3\, Amyotrophic Lateral Sclerosis.\nStudy: Ef
 ficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Pati
 ents\nEstimated primary completion: December 2027. This is a ClinicalTrial
 s.gov estimate\, not a confirmed readout date\, and it can move.\nDrug pag
 e: https://assetmemo.bio/drug/masitinib#upcoming-events\nRegistry record: 
 https://clinicaltrials.gov/study/NCT03127267
URL:https://assetmemo.bio/drug/masitinib#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT05564169-787@assetmemo.bio
DTSTAMP:20261121T004052Z
DTSTART;VALUE=DATE:20281231
DTEND;VALUE=DATE:20290101
SUMMARY:Masitinib: Phase 3 readout est. (NCT05564169)
DESCRIPTION:Masitinib\, phase 3\, Alzheimer's Disease.\nStudy: Masitinib in
  Patients With Mild Alzheimer's Disease\nEstimated primary completion: Dec
 ember 2028. This is a ClinicalTrials.gov estimate\, not a confirmed readou
 t date\, and it can move.\nDrug page: https://assetmemo.bio/drug/masitinib
 #upcoming-events\nRegistry record: https://clinicaltrials.gov/study/NCT055
 64169
URL:https://assetmemo.bio/drug/masitinib#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07174492-787@assetmemo.bio
DTSTAMP:20261121T004052Z
DTSTART;VALUE=DATE:20281231
DTEND;VALUE=DATE:20290101
SUMMARY:Masitinib: Phase 3 readout est. (NCT07174492)
DESCRIPTION:Masitinib\, phase 3\, Amyotrophic Lateral Sclerosis.\nStudy: Ef
 ficacy and Safety of Masitinib in Combination With SoC Versus Placebo in t
 he Treatment of ALS Patients\nEstimated primary completion: 31 December 20
 28. This is a ClinicalTrials.gov estimate\, not a confirmed readout date\,
  and it can move.\nDrug page: https://assetmemo.bio/drug/masitinib#upcomin
 g-events\nRegistry record: https://clinicaltrials.gov/study/NCT07174492
URL:https://assetmemo.bio/drug/masitinib#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
